Vincerx Pharma, Inc.
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibit…
Biotechnology
US, Palo Alto [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Vincerx Pharma, Inc. (VINC) to it's peer group.
Peer Group
STTK MNPR XOMA RZLT TARA VCNX APLT FRTX SPRO PCSA NLTX TCON SRZN BOLT SNTI BCAB SIOX LYRA MIRO CHRS
Compare Together
Loading...